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ABSTRACT
Neuroendocrine tumors of the small bowel are rare malignancies that often occur in 
the case of bowel obstruction or intestinal bleeding. The present case is a 46-year-old 
man who underwent emergency surgery for obstruction due to a rare presentation of 
multiple neuroendocrine lesions located in an intestinal loop. Pathology showed 15 
NETs (grade 1) between 4 and 15 mm diameter with positive lymph nodes and liver 
metastases already detected by the preoperative CT scan. 
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Background:
Primary small bowel malignant tumors represent only 
1-2% of all gastrointestinal neoplasms. Neuroendocrine 
tumors (NET) are classiÀ ed as a rare subgroup of 
malignant diseases, although they are the second most 
common malignant tumors of the small bowel after 
adenocarcinoma.[1, 2]
These tumors are asymptomatic for a long time, or 
they occur with gastrointestinal bleeding, carcinoid 
syndrome, abdominal pain or bowel obstruction; thus, 
their diagnosis is often challenging.[3]
Case Report:
Our patient is a 46-year-old man admitted for abdominal 
pain and intestinal obstruction. 
Diabetes and hypertension are reÁ ected in his case 
history. A CT scan of the abdomen revealed a small 
bowel stenosis of about 4 cm in its proximal tract 
associated with intussusception, multiple metastases in 
the liver and lymph nodes. The radiologist suspected a 
neuroendocrine tumor of the ileum due to the typical 
hypervascularization of these metastases. 
During surgery, multiple intestinal nodules were 
detected, and a small bowel resection was performed (67 
cm in length, Figure 1).
The pathology report showed multiple NET lesions (15 
tumors, diameter between 4 and 15 mm, grade 1, Figure 
2). Metastases were found in 11 of the 34 total analyzed 
lymph nodes. 
The patient underwent adjuvant oncological treatment.
Figure 1: View of the surgical specimen
Discussion:
NETs of the small bowel commonly occur as a 
surgical emergency with symptoms of obstruction and 
intussusception as in the present case. 
Moreover, according to international guidelines, surgical 
treatment is recommended in the case of multiple 
intestinal NET lesions[4]. Multiple tumors are found in 
up to 40% of cases[5], and even small tumors under 1 cm 
may show early lymph node metastases. 
NETs larger than 2 cm have an increased risk of metastases 
in the lymph nodes and liver with a probability of 80% 
and 20%, respectively[6]. Carcinoid syndrome, which 
occurs in 20-30% of patients with NETs, is often (95%) 
associated with the presence of liver metastases[4]. 
In our case, the CT scan suggested the type of disease 
through the typical metastases’ characteristics. The À nal 
diagnosis was only possible after surgical exploration 
and subsequent pathological analysis. 
In our patient, the diameter of the lesions detected was 
between 0.4 and 1.5 cm, without carcinoid syndrome 
but with liver and lymph node metastases. In cases with 
distant metastases, the decision of whether to resect 
the primary tumor or not is based on the following 
considerations[4]: 
1. Achieving R0 resection including the primary tumor 
and distant metastases (curative intent). 
2. In patients with symptoms due to intestinal 
obstruction or bleeding, palliative resection of the 
primary tumor is mandatory as a life-saving treatment. 
Moreover, mesenteric pathological lymph nodes should 
be removed as completely as possible to avoid occlusion 
of vessels with consequent intestinal ischemia. 
3. Non-curative primary tumor resection in metastatic 
disease seems to improve overall survival and therefore 
may be considered. This evidence is shown in a recent 
systematic review of the literature that analyzed data 
from six comparative observational studies[7]. 
The prognosis for patients with NETs depends on both 
disease staging and grading. Jann et al.[8] reported a 
5-year tumor-speciÀ c survival rate for small bowel NETs 
of 100% for stages I and II, 97.1% for stage III and 84.8% 
for stage IV.
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Figure 2: Internal view of the small bowel showing multiple NETs
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